Works by Zweegman, Sonja

Results: 106
    1

    HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.

    Published in:
    EJHaem, 2024, v. 5, n. 4, p. 815, doi. 10.1002/jha2.918
    By:
    • Minnema, Monique C.;
    • Nasserinejad, Kazem;
    • Hegenbart, Ute;
    • Ypma, Paula F.;
    • Wu, Ka Lung;
    • Kersten, Marie Jose;
    • Croockewit, Sandra;
    • Zweegman, Sonja;
    • Tick, Lidwine;
    • Broijl, Annemiek;
    • Koene, Harry;
    • Bos, Gerard M. J.;
    • Sonneveld, Pieter;
    • Schönland, Stefan O.
    Publication type:
    Article
    2

    Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligible patients with newly diagnosed multiple myeloma, using propensity score matching

    Published in:
    EJHaem, 2021, v. 2, n. 1, p. 66, doi. 10.1002/jha2.129
    By:
    • Moreau, Philippe;
    • Hulin, Cyrille;
    • Zweegman, Sonja;
    • Hashim, Mahmoud;
    • Hu, Yannan;
    • Heeg, Bart;
    • Boer, Carla;
    • Vanquickelberghe, Veronique;
    • Kampfenkel, Tobias;
    • He, Jianming;
    • Lam, Annette;
    • Cote, Sarah;
    • Sonneveld, Pieter
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    <sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
    By:
    • Jauw, Yvonne W. S.;
    • O’Donoghue, Joseph A.;
    • Zijlstra, Josée M.;
    • Hoekstra, Otto S.;
    • Willemien Menke-van der Houven van Oordt, C.;
    • Morschhauser, Franck;
    • Carrasquillo, Jorge A.;
    • Zweegman, Sonja;
    • Taskar, Neeta Pandit-;
    • Lammertsma, Adriaan A.;
    • van Dongen, Guus. A. M. S.;
    • Boellaard, Ronald;
    • Weber, Wolfgang A.;
    • Huisman, Marc C.
    Publication type:
    Article
    11
    12
    13

    Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity.

    Published in:
    Supportive Care in Cancer, 2024, v. 32, n. 9, p. 1, doi. 10.1007/s00520-024-08776-w
    By:
    • de Jonge, Nick A.;
    • Janssen, Jeroen J. W. M.;
    • Ypma, Paula;
    • Herbers, Alexandra H. E.;
    • de Kreuk, Arne;
    • Vasmel, Wies;
    • van den Ouweland, Jody M. W.;
    • Beeker, Aart;
    • Visser, Otto;
    • Zweegman, Sonja;
    • Blijlevens, Nicole M. A.;
    • van Agtmael, Michiel A.;
    • Sikkens, Jonne J.
    Publication type:
    Article
    14
    15
    16
    17

    Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 6, p. 594, doi. 10.1002/ajh.25777
    By:
    • Harrison, Claire N.;
    • Schaap, Nicolaas;
    • Vannucchi, Alessandro M.;
    • Kiladjian, Jean‐Jacques;
    • Jourdan, Eric;
    • Silver, Richard T.;
    • Schouten, Harry C.;
    • Passamonti, Francesco;
    • Zweegman, Sonja;
    • Talpaz, Moshe;
    • Verstovsek, Srdan;
    • Rose, Shelonitda;
    • Shen, Juan;
    • Berry, Tymara;
    • Brownstein, Carrie;
    • Mesa, Ruben A.
    Publication type:
    Article
    18

    Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 4, p. 355, doi. 10.1002/ajh.23641
    By:
    • Morabito, Fortunato;
    • Bringhen, Sara;
    • Larocca, Alessandra;
    • Wijermans, Pierre;
    • Victoria Mateos, Maria;
    • Gimsing, Peter;
    • Mazzone, Carla;
    • Gottardi, Daniela;
    • Omedè, Paola;
    • Zweegman, Sonja;
    • José Lahuerta, Juan;
    • Zambello, Renato;
    • Musto, Pellegrino;
    • Magarotto, Valeria;
    • Schaafsma, Martijn;
    • Oriol, Albert;
    • Juliusson, Gunnar;
    • Cerrato, Chiara;
    • Catalano, Lucio;
    • Gentile, Massimo
    Publication type:
    Article
    19
    20
    21
    22
    23

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    24

    Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00430-6
    By:
    • van der Horst, Hilma J.;
    • de Jonge, A. Vera;
    • Hiemstra, Ida H.;
    • Gelderloos, Anne T.;
    • Berry, Daniella R. A. I.;
    • Hijmering, Nathalie J.;
    • van Essen, Hendrik F.;
    • de Jong, Daphne;
    • Chamuleau, Martine E. D.;
    • Zweegman, Sonja;
    • Breij, Esther C. W.;
    • Roemer, Margaretha G. M.;
    • Mutis, Tuna
    Publication type:
    Article
    25

    Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0273-x
    By:
    • Dimopoulos, Meletios A.;
    • Jakubowiak, Andrzej J.;
    • McCarthy, Philip L.;
    • Orlowski, Robert Z.;
    • Attal, Michel;
    • Bladé, Joan;
    • Goldschmidt, Hartmut;
    • Weisel, Katja C.;
    • Ramasamy, Karthik;
    • Zweegman, Sonja;
    • Spencer, Andrew;
    • Huang, Jeffrey S. Y.;
    • Lu, Jin;
    • Sunami, Kazutaka;
    • Iida, Shinsuke;
    • Chng, Wee-Joo;
    • Holstein, Sarah A.;
    • Rocci, Alberto;
    • Skacel, Tomas;
    • Labotka, Richard
    Publication type:
    Article
    26
    27
    28

    Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    29

    Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    30

    European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 11, p. 2006, doi. 10.3109/10428194.2010.516378
    By:
    • Engelhardt, Monika;
    • Udi, Josefina;
    • Kleber, Martina;
    • Spencer, Andrew;
    • Rocci, Alberto;
    • Knop, Stefan;
    • Bruno, Benedetto;
    • Bringhen, Sara;
    • Pérez-Simón, José A.;
    • Zweegman, Sonja;
    • Driessen, Christoph;
    • Patriarca, Francesca;
    • Gramatzki, Martin;
    • Terpos, Evangelos;
    • Sezer, Orhan;
    • Kropff, Martin;
    • Straka, Christian;
    • Johnsen, Hans E.;
    • Waage, Anders;
    • Boegsted, Martin
    Publication type:
    Article
    31
    32

    Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 12, p. 1963, doi. 10.1515/cclm-2021-0399
    By:
    • Noori, Somayya;
    • Verkleij, Christie P. M.;
    • Zajec, Marina;
    • Langerhorst, Pieter;
    • Bosman, Patricia W. C.;
    • de Rijke, Yolanda B.;
    • Zweegman, Sonja;
    • VanDuijn, Martijn;
    • Luider, Theo;
    • van de Donk, Niels W. C. J.;
    • Jacobs, Joannes F. M.
    Publication type:
    Article
    33
    34

    Ixazomib for the treatment of multiple myeloma.

    Published in:
    Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 17, p. 1949, doi. 10.1080/14656566.2018.1528229
    By:
    • Richardson, Paul G.;
    • Zweegman, Sonja;
    • O'Donnell, Elizabeth K.;
    • Laubach, Jacob P.;
    • Raje, Noopur;
    • Voorhees, Peter;
    • Ferrari, Renda H.;
    • Skacel, Tomas;
    • Kumar, Shaji K.;
    • Lonial, Sagar
    Publication type:
    Article
    35

    Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study).

    Published in:
    2021
    By:
    • Harnas, Susan J.;
    • Knoop, Hans;
    • Bennebroek Evertsz, Floor;
    • Booij, Sanne H.;
    • Dekker, Joost;
    • van Laarhoven, Hanneke W. M.;
    • van der Lee, Marije;
    • Meijer, Ellen;
    • Sharpe, Louise;
    • Sprangers, Mirjam A. G.;
    • van Straten, Annemieke;
    • Zweegman, Sonja;
    • Braamse, Annemarie M. J.
    Publication type:
    journal article
    36

    Bortezomib before and after high‐dose therapy in transplant‐eligible patients with newly diagnosed multiple myeloma: Long‐term overall survival after more than 10 years of follow‐up from the phase III HOVON‐65/GMMG‐HD4 trial

    Published in:
    HemaSphere, 2024, v. 8, n. 11, p. 1, doi. 10.1002/hem3.70052
    By:
    • Mai, Elias K.;
    • Nogai, Axel;
    • Lokhorst, Henk M.;
    • van der Holt, Bronno;
    • Zweegman, Sonja;
    • Weisel, Katja C.;
    • Croockewit, Sandra;
    • Jauch, Anna;
    • Hillengass, Jens;
    • Stevens‐Kroef, Marian;
    • Raab, Marc S.;
    • Broijl, Annemiek;
    • Bos, Gerard M. J.;
    • Brossart, Peter;
    • Ypma, Paula;
    • Hanoun, Christine;
    • Bertsch, Uta;
    • Hielscher, Thomas;
    • Salwender, Hans J.;
    • Scheid, Christoph
    Publication type:
    Article
    37

    Preclinical evaluation of the CD38‐targeting engineered toxin body MT‐0169 against multiple myeloma.

    Published in:
    HemaSphere, 2024, v. 8, n. 11, p. 1, doi. 10.1002/hem3.70039
    By:
    • Bruins, Wassilis S. C.;
    • Rentenaar, Rosa;
    • Newcomb, John;
    • Zheng, Wenrou;
    • Ruiter, Ruud W. J.;
    • Baardemans, Thomas;
    • Poma, Eric;
    • Moore, Chris;
    • Robinson, Garrett L.;
    • Lublinsky, Anya;
    • Zhang, Yuhong;
    • Syed, Sakeena;
    • Milhollen, Michael;
    • Dash, Ajeeta B.;
    • van de Donk, Niels W. C. J.;
    • Groen, Richard W. J.;
    • Zweegman, Sonja;
    • Mutis, Tuna
    Publication type:
    Article
    38

    Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes.

    Published in:
    HemaSphere, 2024, v. 8, n. 7, p. 1, doi. 10.1002/hem3.85
    By:
    • Groen, Kazimierz;
    • Smits, Febe;
    • Nasserinejad, Kazem;
    • Levin, Mark‐David;
    • Regelink, Josien C.;
    • Timmers, Gert‐Jan;
    • de Waal, Esther G. M.;
    • Westerman, Matthijs;
    • Velders, Gerjo A.;
    • de Heer, Koen;
    • Leys, Rineke B. L.;
    • van Kampen, Roel J. W.;
    • Stege, Claudia A. M.;
    • Seefat, Maarten R.;
    • Nijhof, Inger S.;
    • van der Spek, Ellen;
    • Klein, Saskia K.;
    • van de Donk, Niels W. C. J.;
    • Ypma, Paula F.;
    • Zweegman, Sonja
    Publication type:
    Article
    39

    Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step‐up dosing.

    Published in:
    HemaSphere, 2024, v. 8, n. 7, p. 1, doi. 10.1002/hem3.132
    By:
    • Korst, Charlotte L. B. M.;
    • Groen, Kaz;
    • Bosman, Patricia W. C.;
    • van der Valk, Fleur;
    • Verkleij, Christie P. M.;
    • Kruyswijk, Sandy;
    • de Ruijter, Maaike E. M.;
    • Heijink, Dianne M.;
    • Kuipers, Maria T.;
    • Zweegman, Sonja;
    • van de Donk, Niels W. C. J.
    Publication type:
    Article
    40

    P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000972904.51933.45
    By:
    • Frerichs, Kristine;
    • Verkleij, Christie;
    • Mateos, Maria‐Victoria;
    • Zweegman, Sonja;
    • Groen, Kaz;
    • Kuipers, Ilse;
    • Martin, Tom;
    • Rodriguez, Cesar;
    • Nooka, Ajay;
    • Kruijswijk, Sandy;
    • Skerget, Sheri;
    • Doyle, Margaret;
    • Banerjee, Arnob;
    • Chastain, Katherine;
    • Perales‐Puchalt, Alfredo;
    • Stephenson, Tara;
    • Uhlar, Clarissa;
    • Kobos, Rachel;
    • Verona, Raluca;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    41
    42
    43
    44

    Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma.

    Published in:
    HemaSphere, 2022, v. 6, n. 10, p. 1, doi. 10.1097/HS9.0000000000000786
    By:
    • Sonneveld, Pieter;
    • Zweegman, Sonja;
    • Cavo, Michele;
    • Nasserinejad, Kazem;
    • Broijl, Annemiek;
    • Troia, Rosella;
    • Pour, Ludek;
    • Croockewit, Sandra;
    • Corradini, Paolo;
    • Patriarca, Francesca;
    • Wu, Kalung;
    • Droogendijk, Jolanda;
    • Bos, Gerard;
    • Hajek, Roman;
    • Petrucci, Maria Teresa;
    • Ypma, Paula;
    • Zojer, Nicholas;
    • Minnema, Monique C.;
    • Boccadoro, Mario
    Publication type:
    Article
    45
    46

    The EHA Research Roadmap: Malignant Lymphoid Diseases.

    Published in:
    HemaSphere, 2022, v. 6, n. 6, p. e726, doi. 10.1097/HS9.0000000000000726
    By:
    • Dreyling, Martin;
    • André, Marc;
    • Gökbuget, Nicola;
    • Tilly, Hervé;
    • Jerkeman, Mats;
    • Gribben, John;
    • Ferreri, Andrés;
    • Morel, Pierre;
    • Stilgenbauer, Stephan;
    • Fox, Christopher;
    • Maria Ribera, José;
    • Zweegman, Sonja;
    • Aurer, Igor;
    • Bödör, Csaba;
    • Burkhardt, Birgit;
    • Buske, Christian;
    • Dollores Caballero, Maria;
    • Campo, Elias;
    • Chapuy, Bjoern;
    • Davies, Andrew
    Publication type:
    Article
    47
    48
    49
    50

    A phase II study of vorinostat ( MK-0683) in patients with polycythaemia vera and essential thrombocythaemia.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 4, p. 498, doi. 10.1111/bjh.12416
    By:
    • Andersen, Christen L.;
    • McMullin, Mary F.;
    • Ejerblad, Elisabeth;
    • Zweegman, Sonja;
    • Harrison, Claire;
    • Fernandes, Savio;
    • Bareford, David;
    • Knapper, Steven;
    • Samuelsson, Jan;
    • Löfvenberg, Eva;
    • Linder, Olle;
    • Andreasson, Bjørn;
    • Ahlstrand, Erik;
    • Jensen, Morten K.;
    • Bjerrum, Ole W.;
    • Vestergaard, Hanne;
    • Larsen, Herdis;
    • Klausen, Tobias W.;
    • Mourits‐Andersen, Torben;
    • Hasselbalch, Hans C.
    Publication type:
    Article